
Tempus Stock Surges: Analyzing the Impact of Acquiring AI-Driven Deep Science Ventures
TEM’s Acquisition of Deep 6 AI: A Game-Changer in Clinical Trials and Precision Medicine TEM, a leading technology-enabled services company in the clinical trial industry, recently announced the acquisition of Deep 6 AI, a pioneering artificial intelligence (AI) company specializing in clinical trial matching. This strategic move is poised to revolutionize the clinical trial landscape…